U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Baker Biotech Fund II (A), L.P. (0001551130)
State location: NY | State of Inc.: DE | Fiscal Year End: 1231
Business Address
667 MADISON AVE.
21ST FLOOR
NEW YORK NY 10065
212-339-5600
Mailing Address
667 MADISON AVE.
21ST FLOOR
NEW YORK NY 10065
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
TRIMERIS INC
Current Name:SYNAGEVA BIOPHARMA CORP
0000911326 2012-07-13 director


Items 1 - 1

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
- -   SYNAGEVA BIOPHARMA CORP 3 - --D 100490.0000 1 0000911326 Common Stock

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016